Triple
T10548351
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Janssen Pharmaceuticals |
E248879
|
entity |
| Predicate | divisionOf |
P6848
|
FINISHED |
| Object | Johnson & Johnson Innovative Medicine |
E8888
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Johnson & Johnson Innovative Medicine | Statement: [Janssen Pharmaceuticals, divisionOf, Johnson & Johnson Innovative Medicine]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Johnson & Johnson Innovative Medicine Context triple: [Janssen Pharmaceuticals, divisionOf, Johnson & Johnson Innovative Medicine]
-
A.
Janssen Pharmaceuticals
Janssen Pharmaceuticals is a global pharmaceutical company, part of Johnson & Johnson, known for developing and marketing a wide range of prescription medicines across areas such as immunology, oncology, neuroscience, and cardiovascular disease.
-
B.
Janssen Biotech
Janssen Biotech is a biopharmaceutical company known for developing and manufacturing innovative biologic therapies, including the blockbuster monoclonal antibody Remicade.
-
C.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
-
D.
Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company known for developing and manufacturing innovative medicines in areas such as oncology, immunology, and cardiovascular disease.
-
E.
Johnson & Johnson
chosen
Johnson & Johnson is a multinational healthcare conglomerate best known for its pharmaceuticals, medical devices, and consumer health products.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d381c733c08190ab1dd6239f5f34ae |
completed | April 6, 2026, 9:49 a.m. |
| NER | Named-entity recognition | batch_69d526d305d081909b48d244e1cfa092 |
completed | April 7, 2026, 3:46 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69d93457af7c819090f576ae606c5849 |
completed | April 10, 2026, 5:33 p.m. |
Created at: April 6, 2026, 12:33 p.m.